Women's health Clinical Trials in Fairfax, VA
As of October 2026, 61 paid clinical trials are recruiting for Women's health in Fairfax, Virginia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Fairfax
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
62 clinical trials for Women's health
·Clear filters·A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
A Study of PHST001 in Advanced Solid Tumors
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Study of AVZO-021 in Patients With Advanced Solid Tumors
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Top Research Study Locations in Fairfax
Researchers run research studies in Fairfax, VA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| NEXT Virginia | Advanced Solid Tumor, Advanced Solid Tumors, Solid Tumor | 72 |
| Virginia Cancer Specialists | Endometrial Cancer, Ovarian Cancer, Breast Cancer | 69 |
| Inova Schar Cancer Institute | Breast Cancer, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | 51 |
| NEXT Oncology Virginia | Colorectal Cancer, Advanced Solid Tumors, Breast Cancer | 33 |
| NEXT Oncology | Solid Tumor, Colorectal Cancer, Ovarian Cancer | 23 |
| Inova Fair Oaks Hospital | Ovarian Carcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 | 13 |
| Virginia Cancer Specialists, PC | Esophageal Adenocarcinoma, Metastatic Breast Cancer, Advanced Breast Cancer | 13 |
| Inova Schar Cancer | Advanced Or Metastatic Merkel Cell Carcinoma, Astrocytoma, IDH-Mutant, Grade 4, Colorectal Cancer | 8 |
| Inova Fairfax Hospital | Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Cardiovascular Diseases | 6 |
| George Mason University | Binge Eating Behaviour, Eating Disorders, Ecological Momentary Assessment | 4 |
| NEXT Oncology - Virginia | Advanced Solid Tumors, Breast Cancer, CNS Tumor | 4 |
| NEXT Oncology - Virginia Cancer Specialists | Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, CNS Metastases | 4 |
| O & O Alpan | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 4 |
| Re:Cognition Health | Alzheimers Disease, Amyloid, Bipolar Disorder | 4 |
| Avenzo Therapeutics Recruiting Site | HR+, HER2-, Advanced Breast Cancer, HR+/HER2- Breast Cancer, Advanced Solid Tumor | 3 |
| Dren Investigational Site | Aggressive NK Cell Leukemia, Aplastic Anemias, Bone Marrow Failure Syndromes | 3 |
| GSK Investigational Site | Alzheimer's Disease, Gastrointestinal Neoplasms, Multiple Myeloma | 3 |
| Inova Health Care Services | Angina, Calcium Release Deficiency Syndrome, Femoral Neck Fractures | 3 |
| Inova Health System | Cervical Cancer, Coronary Artery Disease Progression, Coronary Artery Disease Risk Factors Multiple | 3 |
| Inova Schar Cancer Institute Clinical Trials | Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | 3 |
| Lysosomal Rare Disorders Research and Treatment Center | Niemann-Pick Type C Disease, GM1 Gangliosidosis, GM2 Gangliosidosis | 3 |
| Lysosomal and Rare Disorders Research and Treatment Center, Inc. | Fabry Disease, Pompe Disease | 3 |
| Virginia Cancer Specialists PC | Anaplastic Lymphoma Kinase (ALK) Positive, Metastatic Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer (NSCLC) | 3 |
| Inova Schar Cancer Institute - Fairfax - Innovation Park Drive | Biliary Tract Cancers, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous-Cell Carcinoma | 3 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
Active & Upcoming Studies in Fairfax (2026)
Recruiting trials in Fairfax grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (322 active studies)
- Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic · Phase 1 · Sutro Biopharma, Inc.
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
Cardiovascular (7 active studies)
- PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis · Phase 3 · Duke University
- Palliative Care Intervention to Improve Health Related Quality of Life for Patients on Long-Term LVAD Support · Medstar Health Research Institute
Mental health & behavior (4 active studies)
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
- A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1) · Phase 2 · Eli Lilly and Company
Neurology & pain (3 active studies)
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease · Phase 4 · Impax Laboratories, LLC
- MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion · Kuros Biosurgery AG
Diabetes & metabolic (2 active studies)
Eye & vision (2 active studies)
- A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME). · Phase 3 · 4D Molecular Therapeutics
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy · Phase 3 · Regeneron Pharmaceuticals
HIV / STI (1 active study)
- PrEP Intervention in Prince George's County, Maryland · George Mason University
Common conditions studied in Fairfax
- Advanced Solid Tumor (30 active studies)
- Endometrial Cancer (28 active studies)
- Ovarian Cancer (27 active studies)
- Advanced Solid Tumors (25 active studies)
- Breast Cancer (23 active studies)
- Colorectal Cancer (23 active studies)
Leading research sponsors in Fairfax
- AstraZeneca
- Merck Sharp & Dohme LLC
- AbbVie
- Eli Lilly and Company
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Fairfax?
There are approximately 486 recruiting clinical trials in Fairfax, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fairfax pay participants?
Most recruiting trials in Fairfax compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fairfax?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fairfax?
The most common conditions under active study in Fairfax include Advanced Solid Tumor (30), Endometrial Cancer (28), Ovarian Cancer (27), Advanced Solid Tumors (25), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fairfax?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fairfax on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fairfax?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fairfax?
Recruiting research sites in Fairfax include NEXT Virginia, Virginia Cancer Specialists, Inova Schar Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fairfax right now?
The largest active categories in Fairfax are Cancer & tumors (322), Cardiovascular (7), Mental health & behavior (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.